Assignee
PRIME MEDICINE INC
US·0 granted patents·21 pending applications·0 citations·filing 2022–2024
Top patents by PatentIndex Score
21 records- 0173US2025243474A1Genome editing compositions and methods for treatment of chronic granulomatous diseasePRIME MEDICINE INC·Filed 2024·Application pending·0 cites
- 0270US2024011007A1Genome editing compositions and methods for treatment of chronic granulomatous diseasePRIME MEDICINE INC·Filed 2023·Application pending·0 cites
- 0368US2024376466A1Genome editing compositions and methods for treatment of fanconi anemiaPRIME MEDICINE INC·Filed 2024·Application pending·0 cites
- 0468US2025376674A1Split prime editorsPRIME MEDICINE INC·Filed 2023·Application pending·0 cites
- 0567US2024228988A1Compositions and methods for efficient genome editingPRIME MEDICINE INC·Filed 2024·Application pending·0 cites
- 0666US2024301444A1Genome editing compositions and methods for treatment of cystic fibrosisPRIME MEDICINE INC·Filed 2024·Application pending·0 cites
- 0764US2024067940A1Methods and compositions for editing nucleotide sequencesPRIME MEDICINE INC·Filed 2023·Application pending·0 cites
- 0862US2026071211A1Genome Editing Compositions and Methods for Treatment of Friedreich's AtaxiaPRIME MEDICINE INC·Filed 2022·Application pending·0 cites
- 0961US2025073352A1Genome editing compositions and methods for treatment of fragile x syndromePRIME MEDICINE INC·Filed 2022·Application pending·0 cites
- 1061US2024229038A1Genome editing compositions and methods for treatment of wilson's diseasePRIME MEDICINE INC·Filed 2024·Application pending·0 cites
- 1160US2025319202A1Genome editing compositions and methods for treatment of fuchs endothelial corneal dystrophyPRIME MEDICINE INC·Filed 2022·Application pending·0 cites
- 1260US2025011766A1Genome Editing Compositions and Methods for Treatment of Amyotrophic Lateral SclerosisPRIME MEDICINE INC·Filed 2022·Application pending·0 cites
- 1359US2025179483A1Genome editing compositions and methods for treatment of glycogen storage disease type 1bPRIME MEDICINE INC·Filed 2022·Application pending·0 cites
- 1459US2024360476A1Genome Editing Compositions and Methods for Treatment of Myotonic DystrophyPRIME MEDICINE INC·Filed 2022·Application pending·0 cites
- 1558US2025297248A1Methods and compositions for inhibiting mismatch repairPRIME MEDICINE INC·Filed 2022·Application pending·0 cites
- 1657US2024352453A1Genome editing compositions and methods for treatment of retinopathyPRIME MEDICINE INC·Filed 2024·Application pending·0 cites
- 1757US2024167026A1Genome editing compositions and methods for treatment of wilson's diseasePRIME MEDICINE INC·Filed 2023·Application pending·0 cites
- 1854US2025297246A1Modified prime editing guide rnasPRIME MEDICINE INC·Filed 2022·Application pending·0 cites
- 1951US2024382620A1Genome editing compositions and methods for treatment of usher syndrome type 3PRIME MEDICINE INC·Filed 2022·Application pending·0 cites
- 2051US2024424138A1Genome editing compositions and method for treatment of retinitis pigmentosaPRIME MEDICINE INC·Filed 2022·Application pending·0 cites
- 2150US2023059368A1Polynucleotide editors and methods of using the samePRIME MEDICINE INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PRIME MEDICINE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →